✦ LIBER ✦

Leukotriene receptor antagonists: Efficacy and safety in children with asthma

✍ Scribed by Allan Becker

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 51 KB
Volume: 30
Category: Article
ISSN: 8755-6863
DOI: 10.1002/1099-0496(200008)30:2<183::aid-ppul17>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacotherapy of asthma in children, w

Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists

✍ Stephen C. Weisberg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Asthma in adults is generally recognized as a chronic inflammatory airway disease, although this association is less well established in childhood asthma. Thus, recent asthma guidelines have emphasized that asthma treatment should be directed toward the underlying inflammatory aspects of the disease

Role of leukotriene receptor antagonists

Role of leukotriene receptor antagonists in pediatric asthma

✍ James P. Kemp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Long-term safety and efficacy of abatace

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

✍ Nicolino Ruperto; Daniel J. Lovell; Pierre Quartier; Eliana Paz; Nadina Rubio-Pé 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Long-term safety and efficacy of etanerc

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis

✍ Daniel J. Lovell; Andreas Reiff; Olcay Y. Jones; Rayfel Schneider; James Nocton; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye

Six-week trial of nebulized flunisolide

Six-week trial of nebulized flunisolide nasal spray: Efficacy in young children with moderately severe asthma

✍ Elizabeth D. Allen; Elizabeth R. Whitaker; Grace Ryu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

This study evaluated the clinical efficacy of nebulized flunisolide nasal solution (Nasalideா) in young children with moderately severe asthma. Twenty-two asthmatic children, ages 12-72 months, completed this double-blind placebo-controlled study. After a 6-week observation period, 18 patients were

One-year safety study with bambuterol on

One-year safety study with bambuterol once daily and terbutaline three times daily in 2–12-year-old children with asthma

✍ Jasminka P. Zarkovic; Marianne Marenk; Erkka Valovirta; Anna-Leena Kuusela; Graz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The aim of this study was to compare bambuterol oral solution (10 mg) administered once daily in the evening with terbutaline oral solution (0.075 mg/kg body weight) administered three times daily in 2-5-year-old children and to compare bambuterol tablets (10 mg or 20 mg) administered once daily in